"Centro Oncológico con Expertos en el manejo del Cáncer, inmunoterapia, terapias anti hormonales de tercera generación, quimioterapia tradicional, PROTOCOLOS de investigación, Consejo Genético, Expertos en Radioterapia de precisión, CIBERKNIFE, Tomoterapia, IMRT, etc"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at i Can Oncology Center
During the past decade, i Can Oncology Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2022-09-23
2028-09-30
Recruiting
300
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at i Can Oncology Center
According to Clinical.Site data, the most researched conditions in "i Can Oncology Center" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Neoplasms" (1 trials), "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "i Can Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at i Can Oncology Center
Most popular intervention types in "i Can Oncology Center" are "Drug" (7 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (2 trials), "Placebo" (2 trials), "ADT (Standard of Care)" (1 trials), "Abiraterone acetate (AA)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at i Can Oncology Center
The vast majority of trials in "i Can Oncology Center" are
5 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at i Can Oncology Center
Currently, there are NaN active trials in "i Can Oncology Center".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in i Can Oncology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in i Can Oncology Center, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".